Funding: New Awards

View current funding opportunities.

Marie Bakitas, DNSc, APRN, AOCN, FAAN
Assistant Professor
Cancer Control

    Early vs. later palliative cancer care: Clinical and biobehavioral effects

Frederick Lansigan, MD
Assistant Professor
Molecular Therapeutics

  • DMS
    A multicenter, open label, Phase II study of bendamustine and rituximab followed by 90-yttrium (Y) ibritumomab tiuxetan for untreated follicular lymphoma (Fol-BRITe study)